Latest Breaking News On - Sirolimus coated balloon - Page 5 : comparemela.com

Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease – Padovanews

Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease – Padovanews
padovanews.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from padovanews.it Daily Mail and Mail on Sunday newspapers.

United statesCardiovascular research foundationConcept medical incInvestigational device exemptionMagictouch sirolimus coated balloonSmall vesselsConcept medicalSirolimus coated balloonSmall vesselIn stent restenosisVessel diseaseDrug coated balloonsDrug eluting stentsHybrid bifurcationMartin leonChairman emeritus

Concept Medical received IDE clearance to study the safety and efficacy of its MagicTouch sirolimus-coated balloon catheter for the treatment of minor coronary artery disease

Die US-amerikanische Gesundheitsbehörde FDA hat eine IDE-Zulassung (Investigational Device Exemption) für den neuartigen Magic Touch Sirolimus Coated Balloon (SCB) von Concept Medical Inc.

United statesRoshan belloseDrug administrationCardiovascular research foundationConcept medical incClearance for concept medical incInvestigational device exemptionConcept medicalMagic touch sirolimus coated balloonSirolimus coated balloonPre market authorizationMiddle easternHybrid bifurcationMartin leonChairman emeritus

Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease

/PRNewswire/ The US FDA has granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc s novel MagicTouch Sirolimus Coated Balloon.

United statesConcept medical incCardiovascular research foundationInvestigational device exemptionMagictouch sirolimus coated balloonSmall vesselsConcept medicalSirolimus coated balloonSmall vesselIn stent restenosisVessel diseaseSirolimuscoated balloonDrug coated balloonsDrug eluting stentsHybrid bifurcationMartin leon

Concept Medical receives 3rd IDE approval from USFDA for MagicTouch-Sirolimus Coated Balloon

For the treatment of small vessel indication in coronary arteries

United statesConcept medical incDrug administrationSurat based concept medicalInvestigational device exemptionSirolimus coated balloonMagic touchSmall vesselsCoronary in stent restenosisArterial diseasesConcept medicalMagic touch sirolimus coated balloonCoronary artery diseaseDrug coated balloonsDrug eluting stentsHybrid bifurcation

Concept Medical Inc : Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease

TAMPA, Fla., May 1, 2023 /PRNewswire/ The US FDA has granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc's novel MagicTouch Sirolimus Coated Balloon (SCB) for

United statesCardiovascular research foundationConcept medical incInvestigational device exemptionMagictouch sirolimus coated balloonSmall vesselsCoated balloonSmall vesselConcept medicalSirolimus coated balloonIn stent restenosisVessel diseaseDrug coated balloonsDrug eluting stentsHybrid bifurcationMartin leon